openPR Logo
Press release

United States Chagas Disease Market Set for Significant Growth Amid Rising Awareness and Innovative Treatments 2025 | Major key players - Bayer AG, Novartis AG, Maprimed.

09-30-2025 08:55 AM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

Chagas Disease Market

Chagas Disease Market

Market Size and Growth:

The Global Chagas Disease Market size reached US$ 268 million in 2023 and is expected to reach US$ 467 million by 2031, growing with a CAGR of 7.2% during the forecast period 2024-2031.

The Chagas Disease Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/chagas-disease-market?sz

The Chagas Disease Market encompasses the global industry involved in the diagnosis, treatment, and management of Chagas disease, a parasitic infection caused by Trypanosoma cruzi. The market includes pharmaceutical therapies, diagnostic tests, and related healthcare services aimed at early detection, effective treatment, and prevention, driven by rising prevalence in endemic regions and increasing awareness of vector-borne diseases worldwide.

Recent Key Developments of United States (U.S):

CDC Warning on Endemic Status (September 2025): The Centers for Disease Control and Prevention (CDC) released a report and advisory recommending that Chagas disease be reclassified as an endemic disease in the US, indicating a persistent presence and local transmission risk.

Scientific Call for Endemic Status (August/September 2025): Scientists and physicians authored a new report and public statements supporting the inclusion of the United States as an endemic country for Chagas disease to improve awareness, training, and management.

Clinical Trial for New Oral Drug (August 2025): AN2 Therapeutics commenced a Phase 1 first-in-human clinical trial for its oral drug candidate, AN2-502998, for the potential treatment of chronic Chagas disease.

Focus on Local Transmission (July 2025): A study in Florida highlighted concerns about possible autochthonous (local) transmission of Chagas disease in the US, following the capture of hundreds of the vector "kissing bugs" across numerous counties.

New Diagnostic Test for Cure (June 2025): Researchers at the University of Georgia developed and reported on a new, highly sensitive test protocol to accurately detect the Trypanosoma cruzi parasite at low levels, which could serve as the first reliable "test of cure" for Chagas disease treatments in humans, dogs, and macaques.

List of the Key Players in the Chagas Disease Market:

Bayer AG
Novartis AG
Laboratorio Elea Phoenix
Maprimed
Nortec Quimica SA
Upsher-Smith Laboratories, Inc
Merck and Co
ChemFish Tokyo Co., Ltd
Anant Pharmaceuticals Pvt. Ltd
InBios International Inc.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=chagas-disease-market

Segments Covered in the Chagas Disease Market:

By Type: Acute Chagas Disease, Chronic Chagas Disease.

By Drugs: Benznidazole , Nifurtimox, Others.

By Route of administration: Oral , Parenteral.

By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/chagas-disease-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Chagas Disease market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Chagas Disease Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Chagas Disease market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Chagas Disease Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Chagas Disease Market in 2025?
◆ What is the projected growth rate of the Chagas Disease Market through 2033?
◆ Who are the key players in the Chagas Disease Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Chagas Disease Market Set for Significant Growth Amid Rising Awareness and Innovative Treatments 2025 | Major key players - Bayer AG, Novartis AG, Maprimed. here

News-ID: 4203485 • Views:

More Releases from DataM Intelligence 4Market Research

United States Porous Ceramic Market Set to Soar: Innovative Applications Drive Global Growth Surge 2025 | Major key players - CoorsTek, Innovacera, Porvair PLC.
United States Porous Ceramic Market Set to Soar: Innovative Applications Drive G …
Market Size and Growth: The Global Porous Ceramic Market size reached US$ 6.7 billion in 2023 and is expected to reach US$ 14.7 billion by 2031, growing with a CAGR of 10.3% during the forecast period 2024-2031. The Porous Ceramic Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed
United States Antiphospholipid Syndrome Market Set to Surge with Innovative Treatments and Growing Awareness by 2031 | Top key players - F. Hoffmann-La Roche, Sanofi S.A, LGM Pharma.
United States Antiphospholipid Syndrome Market Set to Surge with Innovative Trea …
Market Size and Growth: The Global Antiphospholipid Syndrome (APS) Market size reached US$ 32.87 billion in 2023 and is expected to reach US$ 68.43 billion by 2031 growing with a CAGR of 9.6% during the forecast period 2024-2031. The Antiphospholipid Syndrome Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make
United States Pemphigus Vulgaris Treatment Market Set for Rapid Growth Amid Rising Autoimmune Disease Cases 2025 | Top key players - Novartis AG, Sanofi, AbbVie Inc.
United States Pemphigus Vulgaris Treatment Market Set for Rapid Growth Amid Risi …
Market Size and Growth: The Global Pemphigus Vulgaris Treatment Market size reached US$ 473.4 million in 2023 and is expected to reach US$ 896.1 million by 2031 growing with a CAGR of 8.3% during the forecast period 2024-2031. The Pemphigus Vulgaris Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to
United States Compartment Syndrome Treatment Market Set to Surge with Innovative Therapies and Rising Clinical Awareness 2025 | Major key players - Stryker, BD, C2DX, Inc.
United States Compartment Syndrome Treatment Market Set to Surge with Innovative …
Market Size and Growth: The Global Compartment Syndrome Treatment Market size reached US$ 316.8 million in 2023 and is expected to reach US$ 516.6 million by 2031 growing with a CAGR of 6.3% during the forecast period 2024-2031. The Compartment Syndrome Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to

All 5 Releases


More Releases for Chagas

Chagas Disease Market Emerging Trends and Growth Prospects 2034
Introduction Chagas disease, also known as American trypanosomiasis, is a potentially life-threatening parasitic illness caused by Trypanosoma cruzi. It is transmitted primarily through triatomine bugs (kissing bugs), blood transfusions, congenital infections, or contaminated food. Once considered confined to Latin America, globalization, migration, and increased travel have made Chagas disease a global public health concern. While millions are infected worldwide, the disease remains classified as a neglected tropical disease (NTD), with limited treatment
Chagas Disease Treatment Market: An In-Depth Analysis
The global Chagas Disease Treatment Market was valued at approximately USD 450 million in 2024 and is projected to reach around USD 700 million by 2033, growing at a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033 . Chagas Disease Treatment Market Overview Chagas disease, caused by the Trypanosoma cruzi parasite, remains a significant public health challenge, particularly in Latin America. The market's growth is driven by increasing awareness,
Chagas Disease Drug Market Size, Share, Growth Forecast 2023-2032
Chagas disease, caused by the parasite Trypanosoma cruzi, remains a significant public health concern, particularly in Latin America. With an estimated 6 to 7 million people worldwide affected by this neglected tropical disease, the demand for effective treatments has spurred the growth of the Chagas Disease Drug Market. As of 2022, the market size stood at a commendable USD 265.2 million, and projections indicate a robust expansion, with expectations to
2018 – 2024 Chagas Disease Management Market | Global Industry Report
2018 – 2024 Chagas Disease Management Market | Global Industry Report A Recent Market Study On Chagas Disease And Its Current Trends And Future Insights Chagas disease or American trypanosomiasis is a tropical parasitic disease caused by Trypanosoma cruzi. It is transmitted by kissing bugs or triatomine bugs. It can also be transmitted through blood transfusions, in pregnancy, and organ transplantation. In early stage of the Chagas disease, the symptoms include swollen
Chagas Disease Treatment Market Global Industry Insights, and Forecast till 2025
Chagas disease is an endemic in 21 Latin American countries caused by kinetoplastid protozoan parasite, Trypanosoma cruzi, primarily transmitted by large, blood-sucking reduviid insects widely known as 'the kissing bugs'. Moreover, the disease can be transferred through other means such as blood transfusion, organ transplantation, as well as congenital and oral transmissions. The recent past has witnessed spread of Chagas disease to developed economies such as Europe and North America,
Chagas Disease Treatment Market - Global Industry Insights, and Forecast till 20 …
Chagas disease is an endemic in 21 Latin American countries caused by kinetoplastid protozoan parasite, Trypanosoma cruzi, primarily transmitted by large, blood-sucking reduviid insects widely known as 'the kissing bugs'. Moreover, the disease can be transferred through other means such as blood transfusion, organ transplantation, as well as congenital and oral transmissions. The recent past has witnessed spread of Chagas disease to developed economies such as Europe and North America,